Symbiotec Pharmalab IPO subscription status
Symbiotec Pharmalab IPO was subscribed 71.26x overall when bidding closed on 27 Aug 2026: QIB 172.03x, NII 73.63x, Retail 12.96x, Employee 15.41x.
Last update: 01 Sep 2026, 06:31 PM IST.
Day-wise subscription
| Day | QIB | NII | Retail | Total |
|---|---|---|---|---|
| 1 Sep 2026 | 172.03x | 73.63x | 12.96x | 71.26x |
The last reading of each day, in IST.
Shares offered by category
| Category | Shares reserved |
|---|---|
| QIB | Not more than 50% of the Net Offer |
| Retail | Not less than 35.00% of the Net Offer |
| NII | Not less than 15% of the Net Offer |
Chances of allotment
The retail category is subscribed 12.96x, so roughly 1 in 13 retail applications may get one lot (a little better if many people applied for more than one lot). This is an estimate. See how IPO allotment works.
See the subscription status of every IPO today, or read what QIB, NII and retail mean.
Frequently asked questions
How many times has Symbiotec Pharmalab IPO been subscribed?
71.26x overall as of 01 Sep 2026, 06:31 PM IST: QIB 172.03x, NII 73.63x, Retail 12.96x, Employee 15.41x.
What are the chances of getting Symbiotec Pharmalab IPO shares?
The retail category is subscribed 12.96x, so roughly 1 in 13 retail applications may get one lot (a little better if many people applied for more than one lot).
When does Symbiotec Pharmalab IPO bidding open and close?
It opens on 24 Aug 2026 and closes on 27 Aug 2026. UPI mandates must be approved by 5 PM on the closing day.
Subscription status of other IPOs
- Jio Platforms IPO subscription status
- Paras Healthcare IPO subscription status
- Core4 Engineers IPO subscription status
- EAAA India Alternatives IPO subscription status
- BLS Polymers IPO subscription status
- SFC Environmental Technologies IPO subscription status
- HD Fire Protect IPO subscription status
- Vaibhav Vyapaar IPO subscription status
- Fusion CX IPO subscription status
- Ravita Engineering Services IPO subscription status
- Bonfiglioli Transmissions IPO subscription status
- Sahajanand Medical Technologies IPO subscription status